Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Walgreens: Don’t call us just a retailer

With CVS Health on the brink of acquiring health insurer Aetna, Walgreens wants to revamp its image as more than a retailer, according to a report by CNBC.

Thumbnail

Healthcare groups warn of consequences over new ACO rules

Industry groups have submitted their final comments on CMS’ recent proposal to overhaul the Medicare Shared Savings Program, warning that some of the new changes could result in fewer accountable care organizations participating in the program.

ACA has helped healthcare stocks boom

The Affordable Care Act has helped launch healthcare stocks into the stratosphere over the last eight years, contrary to what some critics of the healthcare law believed would happen.

New Medicare Advantage plan launches with $300M in funding

Devoted Health, a new Medicare Advantage plan, has officially launched after securing $300 million in a Series B funding round, the company announced.

Thumbnail

Healthcare M&A slows 38% in third quarter

Mergers and acquisition activity among hospitals and health systems is showing signs of a slowdown, according to the latest findings from financial consulting firm Kaufman, Hall & Associates.

Thumbnail

Bloomberg: Athenahealth has five potential bidders

Athenahealth, a network-enabled services company for hospitals and ambulatory clients, has bids from at least five entities, according to a report from Bloomberg.

Thumbnail

Walmart considering selling marijuana as medicine in Canada

As Canada is set to legalize marijuana use on Oct. 17, Walmart—the world’s largest employer—is seriously considering adding cannabis products alongside other medications in its aisles in the country, according to Hemp Industry Daily.

Thumbnail

Drug pricing transparency rule has no teeth

HHS proposed a new rule to require drug manufacturers to publish prices of medicines in television ads. However, the rule has no enforcement mechanism by the agency and relies on self-policing.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup